Thailand's ATMP Ecosystem Development at CPHI South East Asia

Dr. Yodchai Tangjaideborisut Supports Thailand's ATMP Ecosystem Development at CPHI South East Asia

Dr. Yodchai Tangjaideborisut, Secretary of the Biotech Industry Club and CEO & Founder of FG Global, participated in CPHI South East Asia, reaffirming the company's commitment to advancing Thailand's Advanced Therapy Medicinal Products (ATMPs) ecosystem and supporting the country's vision of becoming ASEAN's leading hub for advanced medical innovation.

During the event, the Biotechnology Industry Club under the Federation of Thai Industries (FTI) organized a high-level seminar titled "Building Thailand's ATMP Ecosystem", bringing together medical professionals, researchers, industry leaders, government agencies, and private-sector stakeholders to strengthen collaboration in the field of advanced therapeutics.

The session focused on developing a robust national ecosystem that supports research, clinical translation, manufacturing capabilities, regulatory frameworks, and commercialization of Advanced Therapy Medicinal Products (ATMPs), including:

Gene Therapy for treating diseases at the genetic level.
Cell Therapy for regenerative medicine and the treatment of complex diseases.
Tissue Engineering for repairing or replacing damaged tissues and organs.
Personalized Medicine, delivering precision therapies tailored to individual patients.
Building a comprehensive ATMP ecosystem is a strategic national initiative aimed at accelerating innovation, enhancing healthcare capabilities, and positioning Thailand as a regional leader in advanced medical technologies.

As a company dedicated to Biotechnology, Nutraceuticals, Functional Foods, and Health Innovation, FG Global believes that strong collaboration among the medical community, academia, industry, and government is essential to driving sustainable innovation and improving future healthcare outcomes.

Dr. Yodchai's participation reflects FG Global's commitment to supporting scientific advancement, fostering strategic partnerships, and contributing to Thailand's long-term vision of becoming a regional center for Advanced Therapy Medicinal Products (ATMPs) and next-generation healthcare innovation.